Touchlight Genetics

company

About

Touchlight Genetics develops a DNA production platform designed for the development of DNA vaccines for oncology and infectious diseases.

Details

Last Funding Type
Grant
Last Funding Money Raised
$2.40M
Industries
Biopharma,Biotechnology,Health Care,Medical
Founded date
Jan 1, 2007
Number Of Employee
101 - 250
Operating Status
Active
Legal Name
Touchlight Genetics Ltd.

Touchlight Genetics develops a DNA production platform designed for the development of DNA vaccines for oncology and infectious diseases. Founded in 2007, Touchlight brings together a highly talented scientific and drug development team supported by an experienced board.

Founder and CEO Jonny Ohlson has assembled a dynamic management team, including Clive Dix, Non-Executive Chairman, and John Tite, Executive Head of Research (formerly founding CEO of Bicycle Therapeutics), with substantial experience in growing life science companies and particularly in DNA vaccines. Touchlight is supported by a group of Non-Executive Directors, who bring a wealth of healthcare and entrepreneurial experience.

Led by experienced drug pharmaceutical scientists Neil Porter and Jill Makin, Touchlight’s scientific team- some of the brightest talents in the UK industry- has successfully established and patented the proTLx™ synthetic DNA platform as well as successfully establishing the first therapeutic proof-of-principle through collaboration with leading academic partners.

The company has established strong collaborative links with academic laboratories worldwide including Imperial College London, Southampton University, Queen’s University Belfast and the University of Pennsylvania in the US.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
10
$2.40M £92M
Touchlight Genetics has raised a total of $2.40M £92M in funding over 2 rounds. Their latest funding was raised on Nov 28, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 28, 2022 Grant $2.40M 1 Bill & Melinda Gates Foundation Detail
Sep 15, 2021 Series Unknown £50M 2 Bridford Investments
Novator Partners
Detail
Mar 11, 2021 Series Unknown £42M 1 Bridford Investments Detail
Dec 4, 2020 Series Unknown 1 Detail
Dec 12, 2017 Grant 1 Innovate UK Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Touchlight Genetics has made 1 investments. Their most recent investment was on Jul 20, 2016, when Revolut raised £1M.
Date Company Name
Round Money Raised Industry Lead Investor
Jul 20, 2016 Revolut
Equity Crowdfunding £1M Banking

Investors

Number of Lead Investors
Number of Investors
5
5
Touchlight Genetics is funded by 5 investors. Bill & Melinda Gates Foundation and Bridford Investments are the most recent investors.
Investor Name Lead Investor Funding Round
Bill & Melinda Gates Foundation Yes Grant
Bridford Investments Yes Series Unknown
Novator Partners Yes Series Unknown
Innovate UK Yes Grant
Downing Ventures Series Unknown

Employee Profiles

Number of Employee Profiles
4
Touchlight Genetics has 4 current employee profiles, including Board member Birgir Ragnarsson
Board member
Executive
Board member
Executive